Overview

Direct Renin Inhibition and the Kidney

Status:
Completed

Trial end date:
2011-11-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to determine the magnitude of the effect of direct renin inhibition by VTP-27999 on renal plasma flow and kidney function.

Phase:

Phase 1

Details

Lead Sponsor:

Vitae Pharmaceuticals, Inc.

Collaborator:

Brigham and Women's Hospital